Mesoblast Limited 6-K Report: December 2024 Filing Highlights

Here are the key insights extracted from the provided section of the financial report (Form 6-K) for Mesoblast Limited:
- Filing Information:
- Document Type: 6-K
- Commission File Number: 001-37626
- Date of Filing: December 19, 2024
- Company Overview:
- Company Name: Mesoblast Limited
- Jurisdiction: Australia
- Principal Executive Office Address:
- Level 38, 55 Collins Street, Melbourne 3000, Australia
- Executive Officer:
- Chief Executive Officer: Silviu Itescu
- Annual Report Filing:
- The registrant indicated it will file annual reports under Form 20-F.
- Recent Announcement:
- On December 18, 2024, Mesoblast Limited filed a new release announcement with the Australian Securities Exchange, referenced as Exhibit 99.1 in this report.
- Signatures:
- The report is signed by Paul Hughes, who is the Company Secretary, indicating formal approval of the document and its contents.
- Exhibits:
- The report includes a reference to a press release (Exhibit 99.1) dated December 18, 2024, which may contain important updates or information regarding the company's operations or financial status.
Overall, this report provides a regulatory update from Mesoblast Limited, indicating compliance with SEC requirements, and highlights a recent announcement that could be significant for stakeholders. Further details would be contained in the referenced press release in Exhibit 99.1.